A new achievement in cell therapy area was reached by the professional team of Virginia Contract Research Organization Co., Ltd. (VCRO).
A listed biotech company, which was assisted by VCRO to prepare the application documents in a short period of time, was granted an Orphan Drug Designation (ODD) qualification by EMA.
The professional, integrated and local team of VCRO successfully helped customers in cell therapy area to achieve the next step of product commercialization in Europe.
Along with the global trend in cell therapy development, VCRO is your best partner!